Overview

Impact of Vitamin A on Multiple Sclerosis (MS)

Status:
Unknown status

Trial end date:
2013-08-01

Target enrollment:

Participant gender:

Summary

The aim of this study is the comparison between the effects of supplementation with 25000 IU preformed vitamin A (retinyl palmitate) or placebo for first 6 months and 10000 IU/day for next 6 months on disease activity and progression in patients with Multiple Sclerosis.

Phase:

Phase 4

Details

Lead Sponsor:

Tehran University of Medical Sciences

Treatments:

Retinol palmitate
Vitamin A
Vitamins